PEAK Surgical Announces First Use Of PEAK PlasmaBlade™ In Europe

PEAK Surgical, Inc., announced the first use of its PEAK® Surgery System by surgeons in the European Union, where the innovative tissue dissection system received its CE Mark in January.

Dr. Raul Pellini and Prof. Giuseppe Spriano, ear, nose and throat (ENT) surgeons at Istituti Fisioterapici Ospitalieri (National Cancer Institute) in Rome, performed head and neck surgeries in cancer patients using the PEAK PlasmaBlades™. Additionally, Prof. Spriano hosted a head and neck surgical international course on May 20-21 that also included a live surgery using the PlasmaBlade.

“The PlasmaBlades worked beautifully in the partial laryngectomy and parotid dissection we conducted, producing nearly bloodless procedures,” said Dr. Pellini. “We are very keen for our ENT colleagues to evaluate these innovative devices as we expect that their patients will experience similar positive outcomes.”

“Like their colleagues in the United States, surgeons in Europe are providing positive feedback that the PlasmaBlade allows them to precisely cut tissue and control bleeding during a wide variety of surgical procedures without causing extensive collateral thermal damage to tissues,” said John Tighe, president and chief executive officer of PEAK Surgical. “We expect to see continued uptake of the PEAK Surgery System in Europe, where we believe the PlasmaBlade could eventually be used in more than one million surgical procedures annually.”

The PEAK PlasmaBlade™ is a family of disposable, low-temperature surgical cutting and coagulation devices that offer the exacting control of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral damage. The PlasmaBlade is part of the PEAK® Surgery System, which also includes the PULSAR® Generator. The generator provides pulsed plasma radiofrequency energy to the PlasmaBlade to incise tissue and control bleeding. In the United States, the PEAK Surgery System is cleared for use in general, plastic and reconstructive, ENT, gynecologic, orthopedic, arthroscopic, spinal and neurological surgical procedures. It was launched in the United States in July 2008 and has been used by U.S. surgeons on more than 1,000 patients, including general, gynecologic, and plastic and reconstructive surgeries.

PEAK Surgical has initiated a series of clinical studies, called the PRECISE Studies (Pulsed Plasma Radiofrequency Energy to ReduCe Thermal Injury and Improve Surgical HEaling), to evaluate the use of the PEAK Surgery System in plastic and reconstructive, gynecologic and oncologic surgery. Initial study results are expected later this year.

Source:  Peak Surgical, Inc.

Share your thoughts

Your email address will not be published.